Form 4: Arcturus Therapeutics CFO Andy Sassine Sells 50,000 Shares

Arcturus Therapeutics' Chief Financial Officer, Andy Sassine, sold 50,000 shares of common stock on June 12, 2024, at an average price of $32.03.

Summary

• On June 12, 2024, Andy Sassine, the Chief Financial Officer of Arcturus Therapeutics Holdings Inc., sold 50,000 shares of the company's common stock.
• The sales were executed in open market transactions.
• The weighted average price for the shares sold was $32.03, with individual sales prices ranging from $31.52 to $33.54 per share.
• Following the transaction, Sassine directly owns 220,526 shares of Arcturus Therapeutics.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting an insider stock sale. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways depending on the context and the investor's perspective.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company. Investors often monitor these filings to gain insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may react to the news of the CFO's stock sale, potentially influencing the stock price.

Key Dates